GAIR2021 released the annual Best AI Digital Intelligence list. In the medical field, Keya Medical received the Best Clinical Aided Decision-Making Product Award for its flagship product DeepVessel FFR.

The Global Conference on Artificial Intelligence and Robotics (GAIR2021) was held in Shanghai from December 9-11, 2021. GAIR is organized by, the Chinese Computer Federation (CCF), and the Chinese University of Hong Kong (Shenzhen). Themed “New AI Infrastructure, New Industry Opportunities”, the event was one of the largest cross-industry conferences in China. It brings together the fields of academics, industry, and investment in the field of artificial intelligence and robotics.

Keya Medical, a leading medical technology manufacturer, showcased its deep learning-based diagnostic and treatment solutions. Its flagship product DeepVessel FFR is the first AI-empowered Class III medical device approved by the National Medical Products Administration (NMPA) for commercialization in China. DeepVessel FFR uses deep learning technology to perform a non-invasive physiological functional assessment of the coronary arteries to accurately diagnose whether patients have suffered from myocardial ischemia, based on patients’ computed tomography angiography (CTA) images.

At present, Keya Medical has built an artificial intelligence diagnosis center with more than 1100 hospitals in many provinces and cities in China, covering 30 million patients in total.


Starting from clinical needs, the commercialization of AI products

Keya Medical was represented by Dr. Li Yuwei, a chief scientist at Keya Medical. The main topic of his speech was “starting from clinical needs, the road of commercialization of AI products”.

Dr. Li Yuwei emphasized that the need to improve the long-term uneven distribution of medical resources leads to an increased demand for precision medicine in the clinical diagnosis and treatment of cardiovascular and cerebrovascular diseases. As a leading company in the AI medical industry in China, Keya Medical adheres to the R&D concept of “continuous and effective innovation through AI thinking based on clinical needs, and optimization of diagnosis and treatment path.” Keya Medical has built an AI product service line that can cover the whole process of clinical screening, diagnosis, treatment, and follow-up.

About Keya Medical

Keya Medical is an international medical technology company developing deep learning-based medical devices for disease diagnosis and treatment. The company is committed to creating solutions that deliver clinical value at all stages in the patient care process, covering specialties including cardiology, neurology, pulmonology, pathology, and surgery. Since 2016, Keya Medical has collaborated with more than 725 hospitals to improve diagnostics, care processes, and clinical outcomes. To learn more about Keya Medical, follow us on LinkedIn, Twitter, and Facebook.